Numerous biopharmaceutical companies and researchers are presenting research and clinical trial results at the virtual ASCO 2020 event May 29-31.

This white paper considers how incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.

Syneos Health, the only fully integrated biopharmaceutical solutions organization, announced the appointment of Patrick Nealon as Executive Vice President and General Manager of Oncology Clinical Development.

The IQVIA Institute for Human Data Science found in its latest report – Global Oncology Trends 2019: Therapeutics, Clinical Development and Health System Implications – that in 2018 a record-setting 15 new active substance oncology treatments with 17 indications, including one tissue-agnostic therapy, launched in the U.S.